87 related articles for article (PubMed ID: 9235357)
1. [KAI1/CD82 and ME491/CD63 expression in non-small-cell carcinoma of the lung and prognosis].
Adachi M; Taki T; Ieki Y; Ko S; Higashiyama S; Kodama K; Doi S; Miyake M
Nihon Kyobu Geka Gakkai Zasshi; 1997 Mar; 45(3):398-401. PubMed ID: 9235357
[No Abstract] [Full Text] [Related]
2. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M
Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488
[TBL] [Abstract][Full Text] [Related]
3. CD82, and CD63 in thyroid cancer.
Chen Z; Mustafa T; Trojanowicz B; Brauckhoff M; Gimm O; Schmutzler C; Köhrle J; Holzhausen HJ; Kehlen A; Klonisch T; Finke R; Dralle H; Hoang-Vu C
Int J Mol Med; 2004 Oct; 14(4):517-27. PubMed ID: 15375577
[TBL] [Abstract][Full Text] [Related]
4. KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor: an immunohistochemical analysis.
Higashiyama M; Kodama K; Yokouchi H; Takami K; Adachi M; Taki T; Ishiguro S; Nakamori S; Yoshie O; Miyake M
Cancer; 1998 Aug; 83(3):466-74. PubMed ID: 9690539
[TBL] [Abstract][Full Text] [Related]
5. Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer.
Sho M; Adachi M; Taki T; Hashida H; Konishi T; Huang CL; Ikeda N; Nakajima Y; Kanehiro H; Hisanaga M; Nakano H; Miyake M
Int J Cancer; 1998 Oct; 79(5):509-16. PubMed ID: 9761121
[TBL] [Abstract][Full Text] [Related]
6. Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression.
Adachi M; Taki T; Konishi T; Huang CI; Higashiyama M; Miyake M
J Clin Oncol; 1998 Apr; 16(4):1397-406. PubMed ID: 9552043
[TBL] [Abstract][Full Text] [Related]
7. Expression of KAI1/CD82 in human colorectal tumor.
Wu DH; Liu L; Chen LH; Ding YQ
Di Yi Jun Yi Da Xue Xue Bao; 2003 Jul; 23(7):714-5, 719. PubMed ID: 12865229
[TBL] [Abstract][Full Text] [Related]
8. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of CD151 gene expression in non-small cell lung cancer.
Tokuhara T; Hasegawa H; Hattori N; Ishida H; Taki T; Tachibana S; Sasaki S; Miyake M
Clin Cancer Res; 2001 Dec; 7(12):4109-14. PubMed ID: 11751509
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of KAI1/CD82 protein expression in oral cancer correlates with reduced disease free survival and overall patient survival.
Farhadieh RD; Smee R; Ow K; Yang JL; Russell PJ; Crouch R; Jackson P; Jacobson IV
Cancer Lett; 2004 Sep; 213(1):91-8. PubMed ID: 15312688
[TBL] [Abstract][Full Text] [Related]
11. A novel molecular staging protocol for non-small cell lung cancer.
Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
[TBL] [Abstract][Full Text] [Related]
12. KAI1/CD82 expression as a prognosic factor in sporadic colorectal cancer.
Muneyuki T; Watanabe M; Yamanaka M; Shiraishi T; Isaji S
Anticancer Res; 2001; 21(5):3581-7. PubMed ID: 11848527
[TBL] [Abstract][Full Text] [Related]
13. Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model.
Takeda T; Hattori N; Tokuhara T; Nishimura Y; Yokoyama M; Miyake M
Cancer Res; 2007 Feb; 67(4):1744-9. PubMed ID: 17308116
[TBL] [Abstract][Full Text] [Related]
14. [Effects of a reduction or deviation of metastasis inhibitory factor MRP-1/CD9 on postoperative follow-up results in patients with lung cancer].
O S; Adachi S; Ieki Y; Nakano K; Higashiyama S; Kodama K; Tsuchii O; Taki T; Miyake M
Nihon Kyobu Geka Gakkai Zasshi; 1996 Mar; 44(3):321-3. PubMed ID: 8926405
[No Abstract] [Full Text] [Related]
15. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients.
Huang CI; Kohno N; Ogawa E; Adachi M; Taki T; Miyake M
Am J Pathol; 1998 Sep; 153(3):973-83. PubMed ID: 9736046
[TBL] [Abstract][Full Text] [Related]
16. KAI1/CD82 gene expression in benign prostatic hyperplasia and late-stage prostate cancer in Chinese.
Hu WL; Li YQ; He HX; Li QR; Tian Y; Lai RQ; Mei H
Asian J Androl; 2000 Sep; 2(3):221-4. PubMed ID: 11225981
[TBL] [Abstract][Full Text] [Related]
17. KAI1 gene expression in hepatocellular carcinoma and its relationship with intrahepatic metastases.
Sun HC; Tang ZY; Zhou G; Li XM
J Exp Clin Cancer Res; 1998 Sep; 17(3):307-11. PubMed ID: 9894767
[TBL] [Abstract][Full Text] [Related]
18. Loss of KAI1/CD82 expression in bone and soft tissue tumors is not associated with lung metastasis.
Arihiro K; Inai K
Pathol Res Pract; 2001; 197(9):627-33. PubMed ID: 11569927
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between the levels of KAI1/CD82 and CD44 and the clinicopathological features of non-small cell lung cancer].
Chen QY; Lin XM; Zhou JY; An Z; Yang L; Jiang ZY
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Feb; 27(2):101-4. PubMed ID: 14990184
[TBL] [Abstract][Full Text] [Related]
20. Role of tumor metastasis suppressor gene KAI1 in digestive tract carcinomas and cancer cells.
Wu Q; Ji Y; Zhang MQ; Chen YQ; Chen F; Shi DL; Zheng ZH; Huang YJ; Su WJ
Cell Tissue Res; 2003 Nov; 314(2):237-49. PubMed ID: 12955496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
